NCT05019846View on ClinicalTrials.gov

SRT Versus SRT+ADT in Prostate Cancer

PHASE3RecruitingINTERVENTIONAL
Enrollment

310

Participants

Timeline

Start Date

September 30, 2021

Primary Completion Date

December 1, 2025

Study Completion Date

December 1, 2029

Conditions
Prostate Cancer
Interventions
DRUG

Triptorelin Embonate

single administration before SRT starting

DRUG

Bicalutamide 50 mg

1 dose each day, 7 days before LHRH until 10 days after LHRH administration

Trial Locations (1)

25123

RECRUITING

ASST Spedali Civili of Brescia, Brescia

All Listed Sponsors
collaborator

Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia

OTHER

lead

Marco Lorenzo Bonu

OTHER